Monthly News Roundup - March 2017
Ocrevus Approved for Novel Use Among Multiple Sclerosis Treatments
The much anticipated multiple sclerosis (MS) treatment Ocrevus (ocrelizumab) was given the green light from the FDA this month. Ocrevus is a humanized monoclonal antibody designed...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Multiple Sclerosis | Pharmaceuticals